Introduction
Colorectal carcinoma (CRC) is the second most common cancer in Europe, with the second highest mortality rate [1] . In spite of advances in diagnosis and management resulting in overall improved prognosis for patients with CRC, survival rates remain poor for those with advanced disease at presentation [2] . Improved understanding of the pathogenesis and progression of CRC is therefore desirable, in order to mediate early diagnosis and prevention of metastasis.
N-WASP [neural Wiskott-Aldrich syndrome protein, also termed Wiskott-Aldrich syndrome-like (WASL)] is a key organiser of invadopodia, actin-based structures involved in matrix remodelling [3] [4] [5] [6] . Depletion of N-WASP in breast cancer cells decreased invasion and matrix remodelling [6] and led to decreased motility and metastasis [7] . Thus, N-WASP is potentially a key target for invasion and metastasis of epithelial cancers. In addition to its role in cancer, N-WASP has a scaffolding role in cell-cell adhesion and signalling in epithelial tissues. N-WASP is a positive regulator of Wnt pathway signalling in skin [8] and hair follicle cycling through TGF-beta signalling [9] . N-WASP promotes the integrity of barriers, such as the blood-testis barrier [10] , in kidney podocyte foot processes [11] and in vascular permeability in the lung [12] . N-WASP also mediates myoblast cell-cell fusion during myogenesis [13] . Thus, N-WASP is important for normal tissue architecture and integrity, so careful consideration must be given to whether disruption of N-WASP in cancer would have a positive or a negative effect on progression.
The few studies of N-WASP in human cancers have shown a correlation between increased expression of N-WASP and poor prognosis and/or advanced stage in pancreatic adenocarcinoma [14] , hepatocellular carcinoma [15] , oesophageal squamous carcinoma [16] , and invasive ductal carcinoma of the breast [6] . Conversely, there was decreased expression in clear cell renal cell carcinoma, but a high level of N-WASP correlated with poorer survival [17] . In many human cancer studies, high N-WASP expression was negatively correlated with survival [14, 15, 17] . N-WASP levels were higher in metastatic liver lesions than in primary colonic tumours [18] . Furthermore, the chromosomal locus of N-WASP, 7q, is amplified in 22% of colonic adenomas and 44% of carcinomas [19] . More recently, a genome-wide association study identified several new susceptibility loci for CRC, including 1p36.12, the gene locus of CDC42, an upstream regulator of N-WASP [20] . Therefore, N-WASP is a promising target for investigation in CRC.
To explore the role of N-WASP in intestinal homeostasis or CRC, we deleted N-wasp in a mouse model involving loss of Apc (adenomatous polyposis coli), either homozygously in the short term (3-4 days) or heterozygously, to drive adenoma progression. We also deleted N-wasp in a more rapid model with Apc loss in combination with KRas G12D , which are common genetic alterations driving human CRC [21] . Additionally, we explored the relationship between N-WASP protein levels and a range of clinicopathological parameters in two cohorts of human CRC (early polyp cancers and more advanced cancers). We present new evidence for a role for N-WASP in the regulation of intestinal epithelial differentiation and indicate that it may act as a tumour suppressor against the development of benign precursor lesions of CRC (adenomas).
Materials and methods

Ethics and guidelines
All mouse experiments were compliant with the Animals (Scientific Procedures) Act and UK Home Office Regulations, and conducted with reference to the National Centre for the Replacement, Refinement and Reduction of Animals in Research guidelines [22] .
All work involving human samples was carried out in accordance with national and local guidelines and with reference to the REMARK guidelines [23] . Ethical approval for the Tayside whole tissue blocks was obtained from the Tayside Tissue Bank (request number TR000312). For the Glasgow TMAs, ongoing ethical approval for the use of the TMAs is held by the GRI Academic Unit of Surgery (Research Ethics Committee reference numbers 09/S0703/59 and 12/WS/0152).
Murine models
Mice were bred on a C57BL/6 background and maintained in a pathogen-free unit; experimental cohorts were moved to a non-barrier unit and acclimatised for at least 5 days before induction and monitoring. All mice were maintained on a standard diet of Special Diets and Services (SDS, product code 801730) and water ad libitum. Expression of mutations was controlled by a tamoxifen-inducible, gut-specific promotor, Villin-Cre-ER T2 [24] , combined with the following alleles: Apc fl (Apc580s, MGI: Apctm1Tno) [25] , KRas G12D (MGI: KRastm4Tyj) [26] , and N-wasp fl (MGI: Wasltm2Sbs) [27] . Controls in the long-term N-wasp knockout model were a mix of genotypes, with details of all cohorts provided in the supplementary material, Tables S1-S3 .
Tamoxifen induction
Mice were induced when they reached 20 g weight (age range 6-18 weeks across all cohorts; see supplementary material, Tables S1-S3) 
Mouse sampling
In the short-term models, mice were sacrificed on either day 3 (mice carrying the KRas G12D mutation) or day 4 (mice with wild-type KRas) following induction. Mice reaching the endpoint were sacrificed, and the small intestine and colon were removed, flushed with ice-cold water, opened longitudinally, and pinned, with the luminal surface facing upwards, on a wax-filled Petri dish. Tissue was fixed in formalin for at least 24 h. Tumour counts and measurements were all performed at the endpoint (see supplementary material, Table S3 ).
Tissue processing
Following fixation, the tissue was embedded in paraffin and sections were cut and stained as indicated. Antibody details are provided in Table 1 . For bromodeoxyuridine (BrdU) labelling, 2 or 24 h prior to sacrifice, mice were injected with 250 μl of BrdU (GE Healthcare, Little Chalfont, UK; Cat. No. RPN201) to label dividing cells and stained with anti-BrdU antibody.
Quantification
Images were taken using the Olympus BX51 brightfield microscope, to visualise at least 100 well-oriented half-crypts per anatomical site per mouse. Quantification was performed manually using the cell counter tool in ImageJ.
Human samples
The clinical data linked to both of the Glasgow TMAs were collected and maintained by the GRI Academic Unit of Surgery. The early polyp cancer TMA and the advanced cancer TMA are curated by David Mansouri and James Park, respectively, both Clinical Lecturers in Surgery, under the supervision of Professor Donald McMillan, Professor of Surgical Science.
Whole tissue blocks of normal small intestine and colon, adenoma, and adenocarcinoma were obtained TMA slides were scanned digitally at ×20 magnification using the high-resolution Hamamatsu NanoZoomer HT (Hamamatsu Photonics, Shizuoka, Japan) and uploaded onto the SlidePath Digital Image Hub 4.0 (Leica Biosystems, Buffalo Grove, IL, USA). N-WASP IHC for both TMAs was scored manually using the weighted histoscore method [28] . Images were viewed at ×20 magnification using the SlidePath Hub and scores recorded within the OpTMA window. Each core was assigned a score based on the percentage of cells demonstrating varying degrees of positive N-WASP staining within the cytoplasm (0 = negative, 1 = weak, 2 = moderate, 3 = strong -see supplementary material, Figure S6A ).
Analysis of publicly available datasets
To analyse N-WASP (WASL) mRNA expression in human CRC, the TCGA (Provisional) dataset of colorectal cancer was examined utilising Oncomine and cBioPortal. Using the filters Gene: WASL, Analysis Type: Cancer vs. Normal Analysis, and Cancer Type: Colorectal Cancer, expression values were extracted from Oncomine and analysed in Prism. From the cBioPortal homepage, the query was run by selecting cancer study 'Colorectal Adenocarcinoma (TGCA, Provisional)' and genomic profiles 'Putative copy-number alterations from GISTIC' and 'mRNA Expression z-scores (RNA Seq V2 RSEM)', then entering 'WASL' within the 'Enter gene set' box. Graphs were generated by navigating to the 'plots' tab and selecting to plot 'Putative copy-number alteration' against 'mRNA Expression z-scores (RNA seq V2 RSEM)'. After analysing the resulting graph, the query was repeated using a z-score threshold of −1.2 as the cut-off to define cases of altered gene expression (WASL:EXP < −1.2) and the 'survival curve' tab selected to display the resulting Kaplan-Meier curves for overall and disease-free survival.
Statistics
All statistical analyses and graphs were created using Prism 5 for Max OS X (GraphPad Software, Inc, San Diego, CA, USA), except the human colorectal TMA data, which were analysed using IBM ® SPSS ® Version 22 (IBM Corporation, Armonk, NY, USA), and graphs based on these data and those exported from cBioPortal were generated using R version 3.3.2 (The R Foundation for Statistical Computing). Unless stated otherwise, comparisons between groups were performed using a Mann-Whitney test. All P values are unadjusted. In the tumour model, mice culled for a reason other than reaching the endpoint for the model were included in the survival analysis as censored data.
Results
N-WASP is not required for short-term homeostasis in the intestine or colon
N-WASP is expressed along the entire length of the epithelium of mouse intestine and colon and appears cytoplasmic and membrane-associated ( Figure 1A Figure 1H , black dots) was also unchanged. There was also no effect on apoptosis (cleaved caspase-3-positive) (supplementary material, Figure S1D , black dots) or villus length ( Figure 1I) . Thus, N-WASP is expressed throughout the epithelium of the intestine and colon and its loss does not affect morphology, proliferation, apoptosis, or differentiation or distribution of specialised cell types in the short term.
At 1 year post-induction, N-WASP depletion is sustained, although focal expression was observed (supplementary material, Figure S1E ). Proliferation ( Figure 1C , D and supplementary material, Figure S1A -C, red dots) and apoptosis (supplementary material, Figure S1D , red dots) were unaffected at 1 year following N-WASP loss. However, small but statistically significant increases in both Paneth and goblet cell numbers, but not enteroendocrine cell numbers 
Loss of N-WASP results in increased intestinal epithelial cell migration
Normally, epithelial cells of the intestine are in constant flux from the crypt area, where they arise up toward the top of the villus and eventually slough off [29, 30] . This movement is referred to as migration along the crypt-villus axis and is driven by proliferation, but also involves differential expression of integrins and matrix ligands along the axis [29, 30] . We tested the effect of N-wasp deletion on this migration by treating mice with BrdU and measuring the position of the cells along this axis at 2 and 24 h post-injection. Loss of N-wasp accelerated the migration of BrdU-labelled cells both in young and in older mice (supplementary material, Figure S1F , G). Deletion of Apc abrogates the migration of epithelial cells along the intestinal crypt-villus axis [31] , and in the context of homozygous Apc deletion (Figure 2A) or Apc deletion combined with additional KRas G12D mutation ( Figure 2B ), additional loss of N-wasp did not accelerate migration ( Figure 2E ). Loss of Apc also increases proliferation and crypt height [31] , neither of which was affected by additional loss of N-wasp ( Figure 2C, D) . Thus, the effect of Apc deletion was stronger than that of N-wasp deletion. Loss of N-wasp had no effect on proliferation in the colon (supplementary material, Figure S2A , B).
Loss of N-WASP alters differentiation and migration in a model of short-term homozygous Apc deletion
Homozygous loss of Apc in the intestine is lethal, but in the short term extensive hyperproliferation caused by total Apc loss can be studied up to 4 days past induction [31] . Figure S2C ). This effect was negligible in the presence of KRas G12D (supplementary material, Figure S2C ). There was no effect of N-wasp deletion on the number of enteroendocrine cells (supplementary material, Figure S2D ) or apoptotic cells (supplementary material, Figure S2E ) in any of the genotypes. Thus, N-wasp loss promoted increased Paneth cell numbers, which potentially could affect the Lgr5 + stem cell niche [32, 33] .
N-Wasp knockout increased tumour burden and decreased survival in an Apc-deficient model of tumourigenesis
Heterozygous deletion of Apc drives the formation of adenomas (benign tumours) and microadenomas (very small tumours not visible to the naked eye -examples of histology are provided in the supplementary material, Figure S4A ) in the small intestine of mice with a long latency; combining Apc loss with expression of mutant KRas G12D accelerates this progression by around three-to four-fold [34, 35] . Heterozygous Apc deletion induced tumours in mice with a median survival of around 271 days, but N-wasp loss accelerated progression (median survival 143 days; Figure 4A , black line). Addition of KRas G12D/+ accelerated progression further (median survival 65.5 days), which was not significantly shortened by loss of N-wasp (55.5 days) ( Figure 4B Figure 4D ). There was no significant N-WASP-dependent difference in the size of colonic tumours (supplementary material, Figure S3B ) or Ki67 (proliferation marker) expression (supplementary material, Figure S3C ). The number and size of intestinal lower expression of N-WASP mRNA in cancer versus normal tissue for 7/12 CRC datasets using a cut-off of p ≤ 0.01, 1.5-fold, and the top 10% of underexpressed genes. Specifically, in the TCGA (Provisional) cohort, there was a statistically significant decrease in the expression of N-WASP mRNA in CRC versus normal colorectal tissue (p < 0.001, Figure 5A ).
The TCGA Provisional (http://cancergenome.nih .gov/) dataset was also examined using cBioPortal ( Figure 5B ) and we generated Kaplan-Meier survival curves of patients with low (z-score < −1.2) and normal/high (z-score ≥ −1.2) N-WASP mRNA expression. In this dataset, low N-WASP expression was associated with a statistically significant decrease in disease-free survival (p = 0.016) ( Figure 5C ) and a trend towards poorer overall survival ( Figure 5D ), although not statistically significant (p = 0.06).
N-WASP expression is correlated with differentiation and possible T stage in human early-stage polyp cancers
Tissue from the Tayside Tissue Bank revealed that N-WASP was largely cytoplasmic in human small intestine (supplementary material, Figure S5A ) and colon (supplementary material, Figure S5B ), and was expressed at moderate to high levels in the epithelium throughout the length of the crypt-villus axis. Likewise, N-WASP showed variable intensity in human benign adenomas of the colon (supplementary material, Figure S5C ) and in adenocarcinoma (supplementary material, Figure S5D ). Subsequent approval was obtained from the NHS Greater Glasgow and Clyde Biorepository for access to two Glasgow Royal Infirmary Academic Unit of Surgery colorectal TMAs. The first (screen-detected TMA) contains cores from 182 patients (three cores per tumour) who had undergone resection of early T1/T2 polyp cancers identified via the NHS Bowel Screening Programme, while the second (non-screen-detected TMA) contains cores from 272 patients (four cores per tumour) who underwent surgery for stage I-III CRC between 1997 and 2005.
The patient demographics and clinicopathological features of the tumours are summarised in the supplementary material, Table S4 . The TMA was stained for N-WASP and scored using a weighted histoscore method (supplementary material, Figure S6A ). Patients were divided into groups according to their N-WASP histoscores relative to the median. Chi-squared analysis revealed a correlation between N-WASP expression and age under 65 years at diagnosis (p = 0.007), which may reflect genetic differences in CRCs presenting in younger patients (supplementary material, Table  S5 ). As screening starts from age 50 in Scotland, our cohort had an age range of 50-76 years and a mean age of 65.72 years. Poorly differentiated tumours (n = 4) all expressed high levels of N-WASP (p = 0.044). As this TMA was only recently constructed, survival data are not available as most patients are still living. Table S6 . The correlation between N-WASP and a number of clinicopathological characteristics was again compared by chi-squared analysis (supplementary material, Table S7 ). The only statistically significant correlation was between low N-WASP histoscore and MMR deficiency. Patients were again divided into groups according to their N-WASP histoscores. There was no difference in cancer-specific ( Figure 6A ) or overall ( Figure 6B ) survival between patients with high and low histoscores. When patients were stratified by Dukes stage, there was a divergence of the curves (supplementary material, Figure S6B) , with a trend towards better cancer-specific survival in Dukes B patients with the highest histoscores; however, there were only 70 patients and seven events in this subgroup, and the results were not statistically significant (p = 0.118). We therefore cautiously suggest that further investigation of N-WASP expression in a larger clinical cohort is warranted.
Discussion
Although expressed at moderate levels throughout normal intestinal epithelium, N-WASP knockout in Cancer-specific survival curves (months since surgery) and (B) overall survival curves for patients with tumours with high (median and above, red line, n = 75) and low (below median, black line, n = 78) epithelial IHC histoscores for N-WASP. P value derived from log-rank test.
intestinal epithelial cells gave a surprisingly mild phenotype, with no obvious morphological changes. Loss of N-WASP resulted in a slight increase in the number of Paneth and goblet cells and further displacement of their position along the crypt-villus axis than that caused by Apc loss alone. Loss of N-WASP also increased the distance that cells migrated up along the crypt-villus axis over 24 h. Migration up the crypt-villus axis is thought to be driven mainly by proliferation [30] , so this result was surprising as loss of N-WASP did not alter proliferation. Previous studies found differential expression of integrins and matrix components in crypt-villus regions, which might impact on migration through differential adhesion [36, 37] . N-WASP is also required for matrix remodelling in cancer cells [6, 7] , so might be important for epithelial cell interactions with the basement membrane. N-WASP deletion provides perhaps the first demonstration of a case where migration of intestinal epithelial cells is impacted without alteration of proliferation rates and suggests that the cytoskeleton may be important in crypt-villus migration.
The Paneth cell is a source of Wnt in the intestine and maintains a niche for Lgr5 + stem cells [32, 33] as well as secreting antimicrobial compounds to protect against pathogens and maintain the barrier function [38] . Although Paneth cell numbers were only slightly increased in N-wasp knockouts, this might be significant as the number and location of Paneth cells are tightly regulated in normal epithelium [39] [40] [41] . Furthermore, Paneth cells and goblet cells develop from a common precursor [42] , suggesting why both might increase. N-WASP regulates differentiation and maturation of lymphocytes [27, 43] , pancreatic β cells [44] , and hair follicle progenitor cells [8] . The data presented here suggest that it may have a similar role in cell fate in the intestinal epithelium.
In the Apc fl/+ model, N-wasp knockout increased tumour burden and decreased survival. N-wasp knockout Apc fl/+ animals developed multiple microadenomas, as well as a few larger lesions (supplementary material, Figure S4 ). Increased Paneth cell numbers might thus support more tumour-originating cells [45] . However, preliminary studies using RNA in situ hybridisation did not show any N-WASP-dependent difference in the location of Lgr5 + stem cells within small intestinal villi in any of our models (data not shown).
Although N-wasp knockouts harboured more small lesions, there was no difference in the size of the largest individual tumour or proliferation rate. As mice generally reach the endpoint due to a large tumour causing obstruction of the bowel lumen, this suggests that the difference in survival between the two cohorts is due to earlier initiation of tumourigenesis in N-wasp knockouts. Apc loss alone will increase the proliferative ability of intestinal epithelial cells but further mutations are required in order for tumours to progress to cancer. Therefore, N-WASP may have a tumour suppressive role in early lesions.
Although there is very little known about a role for N-WASP in the GI tract, it stabilises epithelial adherens junctions in cultured cells [46] . Competent adherens junctions may pose a mechanical impediment to adenoma formation in Apc-deficient tissue, suggesting that destabilisation could promote progression [46] . However, we did not detect any significant changes in architecture or E-cadherin staining (not shown) of normal or tumour tissue when N-wasp was deleted. No difference in survival or intestinal tumour burden was observed between Apc fl/+ KRas G12D/+ and Apc fl/+ KRas G12D/+ N-wasp fl/fl mice. Previous research has shown that oncogenic Ras causes a reduction in adherens junction formation, lending further support to the proposed model [47] .
In the early cancer TMA, all of the poorly differentiated tumours showed a high N-WASP histoscore.
There was also a possible correlation between N-WASP histoscore and T stage but this did not reach statistical significance. Returning to this cohort at a later time could provide more samples and help to assess the use of N-WASP histoscore as a prognostic indicator for early cancers. Within the advanced cancer TMA cohort, the only significant correlation was that MMR-deficient tumours had a greater frequency of low than of high N-WASP histoscores. There was no difference in overall or cancer-specific survival between patients with high or low histoscores. However, subgroup analysis revealed poorer survival in patients with Dukes stage A tumours and high epithelial N-WASP histoscores and Dukes B tumours with low histoscores, although the differences were not statistically significant. The lack of statistical significance, however, may be related to the small sample size, as there were only 14 Dukes A patients and 70 Dukes B patients, so the results do not definitively exclude N-WASP as a prognostic indicator. Indeed, the findings from the database searches of Oncomine and cBioPortal show decreased expression of both APC and N-WASP in colorectal adenomas and carcinomas, and that lower N-WASP expression is associated with poorer survival. The clinicopathological data available via such methods, however, are very limited and it would be worthwhile to explore N-WASP in a larger TMA cohort to explore its usefulness as a prognostic biomarker in clinical practice. Table S1 . N-WASP knockout cohorts Table S2 . Intestinal turnover cohorts Table S3 . Tumour cohorts Table S4 . Clinicopathological characteristics of the screen-detected cancer cohort Table S5 . Correlation of N-WASP histoscore and clinicopathological characteristics in the screen-detected cancer TMA Table S6 . Clinicopathological characteristics of the non-screen-detected cancer cohort Table S7 . Correlation of N-WASP histoscore and clinicopathological characteristics in the non-screen-detected cancer TMA
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